Great Basin heads to FDA with staph test; Illumina seals the deal for GenoLogics;

> Great Basin Scientific ($GBSN) submitted its staph ID/R blood culture test to the FDA for 510(k) clearance. Statement

> Illumina ($ILMN) closed its previously-announced deal for lab information management company GenoLogics. Release

> German diagnostic outfit Analytik Jena snagged a CE mark for its hepatitis D test. More

> Veracyte ($VCYT) and the Pulmonary Fibrosis Foundation are teaming up for a U.S. patient survey to get individuals' feedback on being diagnosed with lung diseases. Statement

> Springdale, AK-based NOWDiagnostics snatched up Canada's ZBx to gain ground in rapid, point-of-care diagnostics. Release

And Finally… A New Jersey federal judge ordered a Swiss pregnancy test maker to run corrective ads in U.S. magazines after finding that the company misled consumers about its product. More